Yafang Ma

Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy

Yinjun Lou, Yafang Ma, Shanshan Suo et al. · Leukemia Research · 2015 · 45 citations

Prognostic Factors, Hematological Malignancy, Medicine +8

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Yinjun Lou, Yafang Ma, Jianai Sun et al. · Annals of Hematology · 2015 · 43 citations

Hematological Malignancy, Oncology, Medicine +9

Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia

Yinjun Lou, Yafang Ma, Jianai Sun et al. · Annals of Hematology · 2017 · 27 citations

Hematological Malignancy, Prognostic Assessment, Early Death Prediction +10

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Hong‐Hu Zhu, Yafang Ma, Yu Kang et al. · Frontiers in Oncology · 2021 · 26 citations · Full text

Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Yinjun Lou, Yafang Ma, Chenyin Li et al. · Frontiers of Medicine · 2017 · 22 citations

Prognostic Factors, Hematological Malignancy, Oncology +10